IR-Med Inc. (IRME)
OTCMKTS: IRME · Delayed Price · USD
0.650
+0.050 (8.33%)
Jul 23, 2024, 2:06 PM EDT - Market closed
IR-Med Employees
As of December 31, 2023, IR-Med had 9 total employees, including 6 full-time and 3 part-time employees. The number of employees increased by 1 or 12.50% compared to the previous year.
Employees
9
Change (1Y)
1
Growth (1Y)
12.50%
Revenue / Employee
$3,778
Profits / Employee
-$468,444
Market Cap
45.95M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 9 | 1 | 12.50% |
| Dec 31, 2022 | 8 | -2 | -20.00% |
| Dec 31, 2021 | 10 | 3 | 42.86% |
| Dec 31, 2020 | 7 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
IRME News
- 9 days ago - IR-MED Receives $500,000 Grant from the Israel Innovation Authority to Develop its Platform Technology for the Early Detection of Diabetic Foot Ulcers - GlobeNewsWire
- 2 months ago - IR-MED's PressureSafe™ Reduced Pressure Injuries by 50% During a Usability Study with Clalit, Israel's Largest HMO - GlobeNewsWire
- 3 months ago - IR-MED's PressureSafe™ Receives FDA Listing for the Indication of Decision Support Device for Pressure Injuries - GlobeNewsWire
- 5 months ago - IR-MED Reports 92% Efficacy for PressureSafe™ in Early, Non-Invasive, Skin Color Agnostic Detection of Pressure Injuries - GlobeNewsWire
- 5 months ago - IR-MED to Report New Clinical Efficacy Data for Detection of Pressure Injuries with its AI- Based PressureSafe™ Device at NPIAP 2024 Annual Conference on February 16 - GlobeNewsWire
- 7 months ago - IR-MED Awarded Most Innovative Non-Invasive Diagnostics Technology Developer 2023 by Corporate Vision Magazine - GlobeNewsWire
- 8 months ago - IR-MED Granted Patent in Israel for its AI-Driven Platform Technology: Non-Invasive Analysis of Subcutaneous Tissue - GlobeNewsWire
- 10 months ago - IR-MED Appoints Healthcare Executive and Entrepreneur Tzur Di-Cori as Chief Executive Officer - GlobeNewsWire